Form EFFECT Cidara Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005766 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Tax Refinery Announces Year Round Tax Advisory Model to Help Business Owners Shift From Reactive Filing to Strategic Planning
- Carrie Hessney-Doran Named 2026 International Auctioneer Champion of the Women's Division
- Laifen Expands U.S. Retail Footprint with Costco Launch of Best-Selling SE Hair Dryer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
